Six Heterocyclic Metabolites from the Myxobacterium Labilithrix luteola.
dc.contributor.author | Mulwa, Lucky S | |
dc.contributor.author | Jansen, Rolf | |
dc.contributor.author | Praditya, Dimas F | |
dc.contributor.author | Mohr, Kathrin I | |
dc.contributor.author | Wink, Joachim | |
dc.contributor.author | Steinmann, Eike | |
dc.contributor.author | Stadler, Marc | |
dc.date.accessioned | 2018-03-21T15:35:12Z | |
dc.date.available | 2018-03-21T15:35:12Z | |
dc.date.issued | 2018-02-28 | |
dc.identifier.citation | Six Heterocyclic Metabolites from the Myxobacterium Labilithrix luteola. 2018, 23 (3) Molecules | en |
dc.identifier.issn | 1420-3049 | |
dc.identifier.pmid | 29495640 | |
dc.identifier.doi | 10.3390/molecules23030542 | |
dc.identifier.uri | http://hdl.handle.net/10033/621329 | |
dc.description.abstract | Two new secondary metabolites, labindole A [2-methyl-3-(2-nitroethyl)-3H-indole] (1) and labindole B [2-methyl-3-(2-nitrovinyl)-3H-indole] (2), were isolated from the myxobacteriumLabilithrixluteola(DSM 27648T). Additionally, four metabolites3,4,5and6already known from other sources were obtained. Their structures were elucidated from high resolution electrospray ionisation mass spectrometry (HRESIMS) and 1D and 2D nuclear magnetic resonance (NMR) spectroscopy data and their relative configuration was assigned based on nuclear Overhauser effect (NOE) and vicinal ¹H-NMR coupling data. The compounds where tested for biological activities; labindoles A (1) and B (2) exhibited significant activity against Hepatitis C Virus, 9H-carbazole (3), 3-chloro-9H-carbazole (4) and 4-hydroxymethyl-quinoline (5) showed antifungal activities. Moreover, compound3had weak to moderate antibacterial activities, while labindoles A (1) and B (2) were devoid of significant antifungal and antibacterial effects. | |
dc.language.iso | en | en |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/4.0/ | * |
dc.title | Six Heterocyclic Metabolites from the Myxobacterium Labilithrix luteola. | en |
dc.type | Article | en |
dc.contributor.department | Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7, 38124 Braunschweig, Germany. | en |
dc.identifier.journal | Molecules (Basel, Switzerland) | en |
refterms.dateFOA | 2018-06-12T18:06:44Z | |
html.description.abstract | Two new secondary metabolites, labindole A [2-methyl-3-(2-nitroethyl)-3H-indole] (1) and labindole B [2-methyl-3-(2-nitrovinyl)-3H-indole] (2), were isolated from the myxobacteriumLabilithrixluteola(DSM 27648T). Additionally, four metabolites3,4,5and6already known from other sources were obtained. Their structures were elucidated from high resolution electrospray ionisation mass spectrometry (HRESIMS) and 1D and 2D nuclear magnetic resonance (NMR) spectroscopy data and their relative configuration was assigned based on nuclear Overhauser effect (NOE) and vicinal ¹H-NMR coupling data. The compounds where tested for biological activities; labindoles A (1) and B (2) exhibited significant activity against Hepatitis C Virus, 9H-carbazole (3), 3-chloro-9H-carbazole (4) and 4-hydroxymethyl-quinoline (5) showed antifungal activities. Moreover, compound3had weak to moderate antibacterial activities, while labindoles A (1) and B (2) were devoid of significant antifungal and antibacterial effects. |